Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Mogrify has collaborated with Astellas Pharma to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Page 2 - End Timeline News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from End Timeline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In End Timeline Today - Breaking & Trending Today
ViGeneron signs collaboration agreement with Regeneron Pharmaceuticals
ViGeneron, a Germany-based gene therapy company, has entered a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals.
FDA declines to grant approval for Gilead Sciences' HIV treatment
The US Food and Drug Administration (FDA) has declined to grant approval for Gilead Sciences’ investigational therapy lenacapavir for HIV.
ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva
ViiV Healthcare has secured the US FDA approval for the expanded labelling of Cabenuva (cabotegravir, rilpivirine) to treat HIV-1 in adults.
AbbVie seeks approval for upadacitinib to treat nr-axSpA
Abbvie has submitted applications to the US FDA and the EMA to obtain approvals for upadacitinib (RINVOQ) to treat nr-axSpA.